Skip to main content

Oral Vancomycin in the Control of MRSA Outbreaks in the ICU

  • Conference paper
Book cover Infection in the Critically Ill: an Ongoing Challenge

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a serious problem, both clinically and epidemiologically. Systemic vancomycin is the cornerstone for the therapy of invasive infections due to MRSA. However, vancomycin is potentially toxic and there is an increasing fear that microorganisms resistant to vancomycin such as vancomycin-resistant enterococci (VRE) [1] and vancomycin intermediate Staphylococcus aureus (VISA) will emerge [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. HICPAP (1994) Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAP). MMWR 44: 1–12

    Google Scholar 

  2. Smith TL, Pearson ML, Wilcox KR et al (1999) Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 340: 493–501

    Article  CAS  PubMed  Google Scholar 

  3. Boyce JM, Jackson MM, Pugliese G et al (1994) Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA technical panel on infections within Hospitals. Infect Control Hosp Epidemiol 15: 105–115

    Google Scholar 

  4. Wenzel R, Reagan DR, Bertino JS et al (1998) Methicillin-resistant Staphylococcus aureus outbreak: a consensus panel’s definition and management guidelines. AJIC 26: 102–110

    CAS  Google Scholar 

  5. Working Party Report (1998) Revised guidelines for the control of methicillin-resistant infection in hospitals. J Hosp Infect 39: 253–290

    Article  Google Scholar 

  6. Barrett SP, Mummery RV (1998) Trying to control MRSA causes more problems than it solves. J Hosp Infect 39: 85–93

    Article  CAS  PubMed  Google Scholar 

  7. Brun-Buisson C, Legrand P, Rauss A et al (1989) Intestinal decontamination for control of nosocomial multiresistant Gram-negative bacilli. Ann Intern Med 110: 873–881

    Article  CAS  PubMed  Google Scholar 

  8. Taylor ME, Oppenheim BA (1991) Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 17: 271–278

    Article  CAS  PubMed  Google Scholar 

  9. Fekety R (1997) Guidelines for the diagnosis and management of Chlostridium difficile associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 92: 739–750

    CAS  PubMed  Google Scholar 

  10. Crossley K, Landesman B, Zaske D (1979) An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. II. Epidemiologic studies. J Infect Dis 139: 280–287

    Google Scholar 

  11. Rimland D, Roberson B (1986) Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 24: 137–138

    CAS  PubMed Central  PubMed  Google Scholar 

  12. Brady LM, Thomson M, Palmer MA, Harkness JL (1990) Successful control of endemic MRSA in a cardiothoracic surgical unit. Med J Aust 152: 240–252

    CAS  PubMed  Google Scholar 

  13. Bonten MJM, Hyaden MK, Nathan C et al (1996) Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348: 1615–1619

    Google Scholar 

  14. Linden PK, Miller CB (1999) Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen. Diagn Microbiol Infect Dis 33: 113–120

    Article  CAS  PubMed  Google Scholar 

  15. ATS guidelines (1995) Hospital-acquired pneumonia in adults: diagnosis, assessment, initial therapy, and prevention: a consensus statement. Am J Respir Crit Care Med 153: 1711–1725

    Google Scholar 

  16. Barlett JG, Breiman RF, Mandell LA, File TM Jr (1998) Community-acquired pneumonia: guidelines for management. Clin Infect Dis 26: 811–838

    Article  Google Scholar 

  17. Tedesco F, Markham R, Gurwith M, et al (1978) Oral vaycomycin for antibiotic associated pseudomembranous colitis. Lancet ií: 226–228

    Google Scholar 

  18. Khan MY, Hall WH (1966) Staphylococcal enterocolitis–treatment with oral vancomycin. Ann Intern Med 65: 1–8

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Italia, Milano

About this paper

Cite this paper

de la Cal, M.A., Cerdá, E., Calderón, M., García-Hierro, P., van Saene, H.K.F. (2001). Oral Vancomycin in the Control of MRSA Outbreaks in the ICU. In: van Saene, H.K.F., Sganga, G., Silvestri, L. (eds) Infection in the Critically Ill: an Ongoing Challenge. Topics in Anaesthesia and Critical Care. Springer, Milano. https://doi.org/10.1007/978-88-470-2242-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2242-3_14

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0138-1

  • Online ISBN: 978-88-470-2242-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics